Showing 881 - 900 results of 1,123 for search '"prostate"', query time: 0.05s Refine Results
  1. 881

    PROTON RADIATION THERAPY: CLINICAL APPLICATION OPPORTUNITIES AND RESEARCH PROSPECTS by M. V. Zabelin, V. A. Klimanov, J. J. Galyautdinova, A. S. Samoilov, A. O. Lebedev, E. V. Shelyhina

    Published 2018-03-01
    “…The data obtained from experience of use of proton radiation therapy with passively scattered fascicle for cancer therapy of a prostate at an early stage showed the admixed results in comparison with modern methods of radiation therapy with the modulated intensity. …”
    Get full text
    Article
  2. 882

    Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and no... by Zhirui Zhang, Wenhuan Song, Wenyu Chen, Wenze Cui, Wenyi Chen, Qinheng Zhang, Wenwen Ji, Yinglin Wang, Jiayi Wang, Wenhao Yu, Mingkun Yu, Mingkun Yu, Tao Hao, Hong Jiang

    Published 2025-01-01
    “…In this work, miRNA-related research in colorectal cancer, prostate cancer, leukemia, and brain tumors was analyzed in search of key research trends with clinical potential.MethodsA bibliometric analysis of articles, spanning from 2014 to 2024, was carried out with the major focus laid on four types of cancers. …”
    Get full text
    Article
  3. 883

    Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ by Katarína Benčurová, Theresa Balber, Victoria Weissenböck, Lukas Kogler, Joachim Friske, Verena Pichler, Markus Mitterhauser, Marcus Hacker, Cécile Philippe, Marius Ozenil

    Published 2025-01-01
    “…In vitro, similar specific uptake was observed in both PC3 prostate cancer cells and CHO-K1 Chinese hamster ovary cells. …”
    Get full text
    Article
  4. 884
  5. 885

    Preferred labels and language to improve communication about lesions at low risk of progressing to cancer: qualitative interviews with patients and physicians by Antonio Finelli, Anna R Gagliardi, Frances C Wright, Rachel Kupets, Mavis S Lyons, Clara Baker, Genevieve Chaput, Nicole J Look Hong

    Published 2025-01-01
    “…Objectives We explored how to improve communication about low-risk lesions including labels, language and other strategies.Design Qualitative description and thematic analysis to examine the transcripts of telephone interviews with patients who had low-risk lesions and physicians; and mapping to Communication Accommodation Theory to interpret themes.Setting CanadaParticipants 15 patients: 6 (40%) bladder, 5 (33%) prostate and 4 (27%) cervix lesions; and 13 physicians: 7 (54%) cervix, 3 (23%) bladder and 3 (23%) prostate lesions.Main outcome measures Patient and physician views of labels, language and other strategies to improve communication about low-risk lesions.Results Patients and clinicians held discordant views about low-risk lesion label impact, preferences and rationale. …”
    Get full text
    Article
  6. 886

    Benign Adrenocortical Tumors and the Detection of Nonadrenal Neoplasia by Meng Hao, Miguel Angel Luque-Fernandez, Diana Lopez, Kathryn Cote, Jessica Newfield, Molly Connors, Anand Vaidya

    Published 2019-01-01
    “…Patients with benign adrenocortical tumors had higher odds of detected pancreatic IPMN, as well as thyroid nodules, parathyroid tumors, benign breast masses, and prostate hyperplasia compared with patients with normal adrenal glands. …”
    Get full text
    Article
  7. 887

    Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone by Yan-Jiao Wang, Jun-Kun Zhan, Wu Huang, Yi Wang, Yuan Liu, Sha Wang, Pan Tan, Zhi-Yong Tang, You-Shuo Liu

    Published 2013-01-01
    “…There were no significant differences between groups of low-dose TU and standard dose TU in the percentage of changes of these data since the 18th month followup and throughout the study. No side effects on prostate glands including prostate specific antigen were found. …”
    Get full text
    Article
  8. 888
  9. 889
  10. 890

    The Impact of Immune System in Regulating Bone Metastasis Formation by Osteotropic Tumors by Lucia D’Amico, Ilaria Roato

    Published 2015-01-01
    “…Bone metastases are frequent and debilitating consequence for many tumors, such as breast, lung, prostate, and kidney cancer. Many studies report the importance of the immune system in the pathogenesis of bone metastasis. …”
    Get full text
    Article
  11. 891

    Pharmacological activities of some triazinopyrazolothieno pyrimidine derivatives by Bahashwan Saleh A.

    Published 2017-09-01
    “…Compounds 1–5 were also screened for anticancer activity on a human lung cancer cell line (A549) and a human prostate cancer cell line (DU145) using the MTT micro-cultured tetrazolium assay method. …”
    Get full text
    Article
  12. 892

    Magnetic Targeting of Rhodamine-Labeled Superparamagnetic Liposomes to Solid Tumors: In Vivo Tracking by Fibered Confocal Fluorescence Microscopy by Marie-Sophie Martina, Jean-Paul Fortin, Laure Fournier, Christine Ménager, Florence Gazeau, Olivier Clément, Sylviane Lesieur

    Published 2007-03-01
    “…Polyethylene glycol (PEG)ylated and rhodamine-labeled liposomes loaded with maghemite nanocrystals provide a novel nanoscaled hybrid system for magnetic targeting to solid tumors in possible combination with double in vivo imaging by fluorescence microscopy and magnetic resonance imaging (MRI). Human prostate adenocarcinoma tumors implanted in mice were used as a system model. …”
    Get full text
    Article
  13. 893

    Cytotoxicity of Alkyl Derivatives of Protocetraric Acid by Danielle Bogo, Glaucia Alcantara, Ana Camila Micheletti, Neli Honda, Maria de Fátima Cepa Matos

    Published 2025-01-01
    “…In this work, we evaluated through the sulforhodamine B (SRB) assay the cytotoxic activity of seven alkyl ether derivatives of protocetraric acid (9´-O-alkyl protocetraric acid) against the following cell lines: HT-29 (colon carcinoma), 786-0 (kidney carcinoma), MCF7 (breast carcinoma), HEP2 (laryngeal carcinoma), PC-03 (prostate carcinoma), B16F10 (murine melanoma), UACC-62 (human melanoma), and NIH/3T3 (mouse embryonic fibroblast).  …”
    Get full text
    Article
  14. 894

    Interaction among Cells of Bone, Immune System, and Solid Tumors Leads to Bone Metastases by Ilaria Roato

    Published 2013-01-01
    “…Bone metastases are a dismal consequence for different types of solid tumors, such as breast, prostate, lung, and kidney cancer. The mechanisms regulating the interactions among bone, immune system, and tumor cells have been deeply investigated, and many studies are ongoing to define the specific role of the different cells in the bone metastatic process. …”
    Get full text
    Article
  15. 895

    Testing Strategies for Detection of Xenotropic Murine Leukemia Virus-Related Virus Infection by Shixing Tang, Indira K. Hewlett

    Published 2011-01-01
    “…Xenotropic murine leukemia virus-related virus (XMRV) is a newly identified gamma retrovirus and may be associated with prostate cancer- (PC) and chronic fatigue syndrome (CFS). …”
    Get full text
    Article
  16. 896

    Primary Mucinous Adenocarcinoma of the Urinary Bladder with Signet-Ring Cells: Description of an Uncommon Case and Critical Points in Its Management by Fabrizio Di Maida, Giuliano Amorim Aita, Daniele Amorim Aita

    Published 2016-01-01
    “…We present an uncommon case of mucinous adenocarcinoma of the bladder (MAB) with signet-ring cells extensively infiltrating prostate gland and pelvic/retroperitoneal lymph node stations and not responsive to usual systemic chemotherapy regimens. …”
    Get full text
    Article
  17. 897

    Obstructive Nephropathy from Misplaced Suprapubic Catheter with Antegrade Migration into the Urethra by Alexander W. Lipinski, Jordan R. Pollock, Nelly Tan, Douglas Rappaport

    Published 2025-01-01
    “…Case Presentation: An 83-year-old male with a history of prostate cancer and prior prostatectomy presented with lower abdominal pain, urethral leakage, and hematuria after a routine suprapubic catheter exchange, which was found to be incorrectly positioned in the bulbar urethra, leading to obstructive nephropathy with mild hydronephrosis. …”
    Get full text
    Article
  18. 898

    Residual clip after laparoscopic radical prostatectomy surgery and radiotherapy. A case report by Ismael Leblanch Hernández

    Published 2022-05-01
    “…Laparoscopic and robotic radical prostatectomy are two treatment options for prostate cancer. These procedures, although advanced, are not without risks. …”
    Get full text
    Article
  19. 899

    Review of Original Research, Processing Evolution, Chemical Constituents, and Pharmacological Effects of Semen Vaccariae by Yan-Feng Li, Ya-Shu Liu, Yuan-Liang Ai, Zheng Liu

    Published 2024-12-01
    “…Currently, research on the chemical constituents and pharmacological effects of SV has made little progress; however, the understanding of specific therapeutic mechanisms of action on clinical conditions, such as cardiovascular, prostate, and osteoporosis remains to be improved. …”
    Get full text
    Article
  20. 900

    Role of aspirin in cancer prevention by Meng Sun, Jun Yu, Jie Wan, Xiaoyun Dou, Xiaoying Chen, Fang Ye

    Published 2024-01-01
    “…The available evidence shows that aspirin can effectively prevent and treat diseases such as rectal, gastric, ovarian, prostate, and lung cancer. Aspirin has been extensively studied for the prevention and treatment of colorectal cancer. …”
    Get full text
    Article